MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 4.7% during the 4th quarter, Holdings Channel reports. The fund owned 68,128 shares of the healthcare conglomerate’s stock after selling 3,327 shares during the quarter. UnitedHealth Group makes up approximately 1.9% of MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH’s investment portfolio, making the stock its 22nd biggest position. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH’s holdings in UnitedHealth Group were worth $36,120,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also modified their holdings of UNH. TimeScale Financial Inc. raised its stake in UnitedHealth Group by 276.9% in the third quarter. TimeScale Financial Inc. now owns 49 shares of the healthcare conglomerate’s stock valued at $25,000 after buying an additional 36 shares in the last quarter. Pflug Koory LLC raised its stake in UnitedHealth Group by 160.0% in the third quarter. Pflug Koory LLC now owns 52 shares of the healthcare conglomerate’s stock valued at $26,000 after buying an additional 32 shares in the last quarter. Belmont Capital LLC raised its stake in UnitedHealth Group by 294.1% in the third quarter. Belmont Capital LLC now owns 67 shares of the healthcare conglomerate’s stock valued at $34,000 after buying an additional 50 shares in the last quarter. O Dell Group LLC increased its position in shares of UnitedHealth Group by 76.9% during the third quarter. O Dell Group LLC now owns 69 shares of the healthcare conglomerate’s stock worth $35,000 after purchasing an additional 30 shares in the last quarter. Finally, Legend Financial Advisors Inc. acquired a new stake in shares of UnitedHealth Group during the third quarter worth about $37,000. 86.31% of the stock is currently owned by institutional investors and hedge funds.
UnitedHealth Group Price Performance
Shares of NYSE:UNH opened at $472.59 on Friday. The business’s 50 day simple moving average is $480.57 and its 200-day simple moving average is $507.41. The firm has a market capitalization of $440.86 billion, a price-to-earnings ratio of 22.30, a price-to-earnings-growth ratio of 1.31 and a beta of 0.69. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.77 and a quick ratio of 0.77. UnitedHealth Group Incorporated has a 12 month low of $449.70 and a 12 month high of $558.10.
UnitedHealth Group (NYSE:UNH – Get Rating) last announced its quarterly earnings results on Friday, January 13th. The healthcare conglomerate reported $5.34 EPS for the quarter, topping the consensus estimate of $5.17 by $0.17. UnitedHealth Group had a return on equity of 27.04% and a net margin of 6.21%. The business had revenue of $82.79 billion for the quarter, compared to analyst estimates of $82.53 billion. During the same quarter in the previous year, the company earned $4.48 EPS. The company’s quarterly revenue was up 12.3% on a year-over-year basis. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 24.91 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 21st. Investors of record on Monday, March 13th were given a dividend of $1.65 per share. The ex-dividend date of this dividend was Friday, March 10th. This represents a $6.60 annualized dividend and a dividend yield of 1.40%. UnitedHealth Group’s dividend payout ratio is currently 31.15%.
Wall Street Analysts Forecast Growth
UNH has been the topic of a number of research analyst reports. Deutsche Bank Aktiengesellschaft lifted their target price on UnitedHealth Group from $615.00 to $617.00 and gave the stock a “buy” rating in a research report on Tuesday, January 24th. Credit Suisse Group raised their price target on UnitedHealth Group from $590.00 to $610.00 and gave the stock an “outperform” rating in a report on Wednesday, December 7th. Stephens reissued an “overweight” rating and set a $605.00 price target on shares of UnitedHealth Group in a report on Tuesday, February 28th. UBS Group lowered their price target on UnitedHealth Group from $590.00 to $550.00 and set a “neutral” rating on the stock in a report on Wednesday, January 18th. Finally, StockNews.com raised UnitedHealth Group from a “buy” rating to a “strong-buy” rating in a report on Wednesday. Three equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $601.61.
UnitedHealth Group Company Profile
UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.
Featured Articles
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Get Rating).
Receive News & Ratings for UnitedHealth Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.